Heterotrimeric G proteins are the most commonly used signal transducers in eukaryotic cells, and they mediate the effects of many pharmaceuticals. In the standard model for G protein signaling, these proteins act at the plasma membrane ( Figure  1 , top panel). An extracellular signal or drug first binds to a plasma-membrane receptor, causing it to catalyze GTP binding by a heterotrimeric G protein tethered to the cytoplasmic face of the plasma membrane. The GTP bound Gα subunit separates from the Gβγ complex, and each component can now bind to and regulate plasma-membrane localized effectors (which are typically enzymes or ion channels) to stimulate cellular responses.
A fundamental feature of this model, that heterotrimeric G proteins only function at the plasma membrane, now needs to be modified based on a report from Dohlman and colleagues in this issue of Cell (Slessareva et al., 2006) . There have been hints for years that heterotrimeric G proteins may function intracellularly. Although these proteins are localized principally to the plasma membrane, small pools of G protein subunits can be detected on intracellular membranes where they have been proposed to act in membrane transport (Jamora et al., 1999; Le-Niculescu et al., 2005) . However, naysayers have been awaiting the identification of specific intracellular effectors for heterotrimeric G proteins, as well as genetic studies showing that intracellular G protein function is physiologically important. The Slessareva et al. (2006) study appears to provide both.
This story revolves around sex in the yeast Saccharomyces cerevisiae. When two cells of opposite mating type meet, each extends a projection toward the other, halts its cell cycle, initiates transcription of genes involved in mating, and eventually fuses with its partner. This mating act requires a set of signaling proteins identified in the 1980s mostly through "sterile" yeast mutants that fail to mate. These signaling proteins include secreted pheromones, plasma-membrane localized pheromone receptors, a Gα protein named Gpa1, Gβ and Gγ subunits, a MAP kinase cascade activated by Gβγ, and a kinase-activated transcription factor that turns on expression of mating genes.
A puzzling feature of the pheromone signaling pathway in yeast has been that Gβγ stimulated all of the known downstream responses. In contrast, all other well-studied heterotrimeric G proteins have an active signaling role for Gα-GTP. A previous report from the Dohlman group (Guo et al., 2003) , however, suggested that yeast Gα may actively signal after all. The authors expressed an activated Gα mutant in wild-type yeast. This mutant protein, Gpa1 Q323L , is stuck in the GTP bound form and should turn on any effectors of Gα-GTP without activating Gβγ. The authors found that the activated Gpa1 mutant stimulated several aspects of the mating response, including morphological changes, activation of MAP kinase, and transcriptional activation of the mating gene FUS1.
To investigate the mechanism of Gα signaling, Slessareva et al. (2006) screened nearly 5,000 gene deletion strains for the ability to suppress transcription of a FUS1-lacZ reporter gene that is induced by activated Gpa1. They characterize two genes required for reporter gene expression, VPS34 and VPS15, which encode the catalytic and regulatory subunits, respectively, of the sole phosphatidylinositol 3-kinase (PI3K) in yeast. The authors use genetic experiments to establish that PI3K mediates all the mating responses induced by Gpa1 Q323L , and that PI3K is physiologically important for pheromone response and mating in wildtype yeast. However, PI3K mutants retain some ability to mate, explaining why they were never detected in screens for sterile mutants. Gα signaling through PI3K assists in the pheromone response but, unlike Gβγ signaling, is not essential for mating. The authors also show that the Gα protein binds directly to PI3K to activate the enzyme. Either subunit of PI3K, when affinity-tagged, can pull down the Gα protein from yeast lysates, and the interactions are direct because the interactions are also observed with purified PI3K subunits and purified Gα. Finally, expressing the activated Gpa1 mutant in yeast activates PI3K and leads to an increase in the level of phosphatidylinositol 3-phosphate (PI3P), the product of PI3K activity.
Here is where things get really interesting. First, the Vps34/15 enzyme is localized to the endosome, and Slessareva et al. (2006) show that the activated Gpa1 mutant also becomes localized, surprisingly, to the endosome rather than to the plasma membrane. Activated Gpa1 appears to stimulate the local production of PI3P, as it promotes the recruitment of the PI3P binding protein Bem1 (fused to green fluorescent protein) to the endosome. A second interesting finding is that although the catalytic subunit of PI3K binds preferentially to the activated form of Gα (as expected for a Gα effector), the regulatory subunit of PI3K can also bind directly to Gα but prefers the inactive GDP bound form. Homology modeling suggests that the regulatory subunit resembles a Gβ protein, and thus Gα-GDP could bind to the regulatory subunit of PI3K in the same manner that it binds to Gβγ to form an inactive G protein heterotrimer.
This work suggests a new model for Gα signaling in the pheromone response (Figure 1 , bottom panel). Gα starts at the plasma membrane in a Gαβγ heterotrimer, but after activation by the pheromone receptor Gα moves to the endosome, where it directly activates PI3K. The PI3P produced by activated PI3K could recruit Bem1 and perhaps other PI3P binding proteins that might assist in the response to pheromone. Gα might then remain at the endosome to cycle between active and inactive forms that bind to different subunits of PI3K.
An interesting feature of the model is that the regulatory subunit of PI3K functions essentially as an alternative to Gβ that binds to Gα-GDP at the endosome. Two other cycles of G protein activity have been recently proposed in which other proteins bind to Gα-GDP in lieu of Gβ. In one case, a divergent Gβ subunit bound to a regulator of G protein signaling (RGS) protein is proposed to bind to Gα-GDP (Robatzek et al., 2001 ). In the second case, proteins with a GoLoco/GPR domain are proposed to bind to Gα-GDP during G protein control of spindle positioning (Wilkie and Kinch, 2005) . In all three cases, it has been genetic studies in model organisms that led to the discovery of new modes of G protein action, and it remains for the biochemists to resolve the molecular details. These intriguing developments suggest that perhaps we should broaden our search for yet more Gβ-like proteins.
Several puzzles about Gα signaling in yeast remain to be resolved. It is unclear how activated Gα might move from the plasma membrane to the endosome, although endocytosis is a possibility. Indeed, the pheromone receptor and Gpa1 both undergo monoubiquitination-mediated endocytosis (Terrell et al., 1998; Wang et al., 2005) , but more data are needed to establish when this movement occurs. Although it is clear that the activated Gpa1 mutant stimulates PI3K activity, one would also like to see evidence that wild-type Gα stimulates PI3K activity in response to pheromone. Does Gα at the endosome really alternately bind to the catalytic and regulatory subunits of PI3K? A full analysis of Gα interactions with PI3K using purified proteins could address this question. Furthermore, structural analysis of Gα-PI3K complexes by X-ray crystallography is an attractive project because unlike most G protein effectors, the PI3K is not an integral membrane protein and thus An extracellular signal activates a plasma membrane receptor to cause Gα to bind to GTP and separate from Gβγ. Both Gα-GTP and Gβγ can activate effectors at the plasma membrane (typically enzymes or ion channels) to generate cellular responses. Gα, Gγ, and Vps15 have lipid modifications that tether these proteins to the membrane. (B) In the new model for yeast pheromone signaling, the initial steps are the same as in the standard model: pheromone activates its receptor to cause Gα to bind to GTP and separate from Gβγ. Gβγ stimulates its effectors at the plasma membrane to activate MAP kinase signaling. In addition, it is proposed that Gα-GTP moves (possibly by endocytosis) to the endosomal membrane where it activates an endosome-localized phosphatidylinositol 3-kinase (PI3K) composed of four subunits including a catalytic subunit Vps34 and a regulatory subunit Vps15. Gα-GTP binds to Vsp34 to activate PI3K activity producing phosphatidylinositol 3-phosphate, which serves as a binding site to recruit proteins to the endosome. Gα-GDP can also bind to Vps15, which resembles a Gβ subunit, without activating PI3K. It is proposed that Gα may undergo cycles of GTP binding and hydrolysis at the endosome, which causes Gα to alternate binding between the two subunits of PI3K.
should be more amenable to crystallization. How does PI3K activation assist in the pheromone response? Slessareva et al. (2006) show that it may help Gβγ to activate MAP kinase, but possible mechanisms for this are hard to fathom given our current knowledge. Finally, the authors propose that Gα might cycle between GDP and GTP bound forms at the endosome, and this would require a nucleotide exchange factor at the endosome to catalyze the cycle. Could this exchange factor simply be an endocytosed pheromone receptor acting in the same manner as it does at the plasma membrane, or is some new exchange factor required? Despite these unresolved issues, Slessareva et al. (2006) make a major contribution to our understanding of heterotrimeric G protein signaling by identifying an intracellular G protein effector and establishing its physiological significance in signaling through rigorous genetic tests.
Is yeast pheromone signaling relevant to signaling in humans? Anyone who doubts this should look to history. Studies of yeast pheromone signaling first established that Gβγ could activate downstream signaling events. The first member of the RGS class of Gα GTPase activators was also identified through studies of pheromone signaling. In both cases, it was years before it was appreciated that signaling in vertebrates works the same way. The identification of PI3K as an intracellular G protein effector is the first major addition to the yeast pheromone signaling pathway in over 10 years. There is already a hint that heterotrimeric G proteins regulate lipid kinases at intracellular membranes in mammalian cells (Jamora et al., 1999) , and we look forward to follow-up studies.
Structurally speaking, the convoluted folds (cristae) of the mitochondrial inner membrane were once viewed simply as a barrier that separated the mitochondria into the inner matrix and the intermembrane space (IMS). The pioneering studies of mitochondrial structure by Mannella, Frey, and coworkers using electron tomography changed this view. They showed that the lamellar and tubular structure of the mitochondrial inner membrane generates a third type of compartment, created by juxtaposition of innermembrane folds. These intra-cristae regions form a barrier to diffusion of proteins (Frey and Mannella, 2000) . This shifting view of mitochondrial structure has important implications for our understanding of apoptosis.
Several apoptogenic proteins, in particular cytochrome c, reside in the mitochondrial IMS. Predictions based on studies using electron tomography suggest that most cytochrome c is "trapped" in the intra-cristae regions, with limited access to the IMS (Figure 1 ). Two steps are required for the release of cytochrome c from mitochondria. The first involves remodeling of
OPA1 and PARL Keep a Lid on Apoptosis
Eyal Gottlieb 1,
